XL820

Known as: XL820-001 
An orally bioavailable, small molecule receptor tyrosine kinase inhibitor with potential antineoplastic activity. XL820 binds to and inhibits the… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Until the 1990s, cytotoxic chemotherapy has been the cornerstone of medical therapy for gastrointestinal (GI) cancers. Better… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2015
2015
OBJECTIVE To investigate the drug targets related to Notch signaling pathway for glioma treatment. METHODS Gene expression… (More)
Is this relevant?
2006
2006
Exelixis just presented phase 1 clinical trial data for three new kinase inhibitors at the 2006 American Society of Clinical… (More)
Is this relevant?